NCT05077020 (SDA) is a clinical trial in Autistic Spectrum Disorder, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT05077020?

NCT05077020 is sponsored by University Hospital, Montpellier.

What condition does NCT05077020 study?

NCT05077020 studies Autistic Spectrum Disorder, Somatic Disorders.

Is NCT05077020 still recruiting?

NCT05077020 is currently completed. Last updated 26 October 2021.

Last reviewed 2021-10-26 · How we verify

NCT05077020: SDA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Somatic Diseases in Autistic Children

Completed Last updated 26 October 2021

What this trial tests

trial in Autistic Spectrum Disorder in 27 participants. Completed in 1 October 2021.

Timeline

1 January 2020

Primary endpoint
1 January 2021

1 October 2021

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Completed
Study type	OBSERVATIONAL
Enrollment	27
Start date	1 January 2020
Primary completion	1 January 2021
Estimated completion	1 October 2021
Sites	1 location across France

Conditions studied

Autistic Spectrum Disorder — all drugs for Autistic Spectrum Disorder →
Somatic Disorders — all drugs for Somatic Disorders →

Sponsor

University Hospital, Montpellier

Who can join

Under 18, any sex, with Autistic Spectrum Disorder or Somatic Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For many reasons, medical monitoring in autistic patients is very difficult. This study is designed to determine the prevalence of comorbid diseases (neurological, cardiac, digestive, dental diseases…) in patients suffering from ASD to prevent them or diagnose them earlier.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autistic Spectrum Disorder

Currently open trials in the same condition.

NCT05910502 — Project AFECT (Autism Family Empowerment Coaching and Training Program) · NA · active not recruiting
NCT05492032 — Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With AS · NA · recruiting

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05077020 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 26 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05077020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing